Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 25.11.2019 | EN | Official Journal of the European Union | C 399/49 |

---

Judgment of the General Court of 19 September 2019 — Unifarco v EUIPO — GD Tecnologie Interdisciplinari Farmaceutiche (TRICOPID)

(Case T-359/18) [(1)](#ntr1-C_2019399EN.01004901-E0001)

(EU trade mark - Opposition proceedings - Application for EU word mark TRICOPID - Earlier national figurative mark TRICODIN - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)

(2019/C 399/58)

Language of the case: Italian

Parties

Applicant: Unifarco SpA (Santa Giustina, Italy) (represented by: A. Perani and J. Graffer, lawyers)

Defendant: European Union Intellectual Property Office (represented by: L. Rampini, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: GD Tecnologie Interdisciplinari Farmaceutiche Srl (Rome, Italy) (represented by: E. Pepe and M. Farinola, lawyers)

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 13 March 2018 (Case R 2150/2017-5), relating to opposition proceedings between GD Tecnologie Interdisciplinari Farmaceutiche and Unifarco.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Unifarco SpA to pay the costs, including those incurred by GD Tecnologie Interdisciplinari Farmaceutiche Srl before the Board of Appeal of the European Union Intellectual Property Office (EUIPO). |

---

---

[Top](#document1)